Lastly, doxycycline withdrawal led to tumor regression and endothelial apoptosis in a doxycycline-inducible RAS (rat sarcoma)-driven INK4a (inhibitor of cyclin-dependent kinase 4a) deficient murine model of melanoma [22]. This evidence concerns the gene CDKN2A and sarcoma.